RADX stock news · Radiopharm Theranostics
Get alerts for RADX
Follow Radiopharm Theranostics (RADX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for RADXFree on the App Store and Google Play, or on the web.
Radiopharm Theranostics shared its latest quarterly results and news about its cancer treatment plans.
Good for RADXRadiopharm reported an A$5.9 million R&D tax refund and progress in three drug studies. The FDA meeting and positive RAD301 imaging results make the update favorable.
12 health care companies saw big changes in their stock prices after the market closed on Friday.
NeutralRadiopharm Theranostics shares fell 6.09% in the after-market session. The article gives no company update, so it does not change the outlook for Radiopharm Theranostics' business.